Aclaris Therapeutics
ACRS
ACRS
106 hedge funds and large institutions have $62.4M invested in Aclaris Therapeutics in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
57% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 53
87% less capital invested
Capital invested by funds: $480M → $62.4M (-$418M)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
Holders
106
Holding in Top 10
–
Calls
$97K
Puts
$72K
Top Buyers
| 1 | +$2.47M | |
| 2 | +$2.13M | |
| 3 | +$1.97M | |
| 4 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$1.85M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.84M |
Top Sellers
| 1 | -$48.4M | |
| 2 | -$47.8M | |
| 3 | -$30.1M | |
| 4 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$19.2M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$11.6M |